Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.47 |
| ▸ | TACR1 known ✓ | P25103 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SNCA | P37840 | 2/20 | 0.41 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL1532727 | 0.97 | FOLH1 (0.48) | FOLH1SLC6A2SLC6A4GLACYP19A1 | |
| Hydrochloric Acid SCHEMBL9714446 | 0.84 | FOLH1 (0.46) | FOLH1SLC6A2SLC6A4GLACYP19A1 | |
| Bromide SCHEMBL9537912 | 0.83 | SNCA (0.46) | FOLH1SLC6A2SLC6A4GLACYP19A1 | |
| Hydrochloric Acid SCHEMBL5149449 | 0.82 | SNCA (0.52) | SLC6A2SLC6A4ALDH1A1MAOATSHR | |
| Hydrochloric Acid SCHEMBL1575597 | 0.81 | SNCA (0.53) | CYP19A1CYP11B1CYP11B2KDM1AMAOA | |
| Hydrochloric Acid SCHEMBL9714813 | 0.80 | ENPP2 (0.44) | MAOBSNCACYP1A2FFAR1FFAR4 | |
| Bromide SCHEMBL7386874 | 0.80 | SNCA (0.44) | SLC6A2SLC6A4CYP19A1CYP11B1CYP11B2 | |
| Bromide SCHEMBL7388733 | 0.78 | SNCA (0.43) | SLC6A2SLC6A4CYP19A1HRH3MAOB | |
| Bromide SCHEMBL6524406 | 0.78 | SNCA (0.55) | SLC6A2SLC6A4ALDH1A1MAOATSHR | |
| Hydrochloric Acid SCHEMBL9714784 | 0.78 | MEN1 (0.62) | SLC6A2SLC6A4MAOAMAOBSNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5166210-A | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1992-11-24 | — | — | US | disclosed |
| US-5028615-A | Treatment of hypersensitivity | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-07-02 | — | — | US | disclosed |
| US-4920133-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |